Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC
NCT05278052 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 190
Last updated 2025-09-10
Summary
Standard Maintenance Therapy versus Local Consolidative Radiation Therapy and standard maintenance therapy in 1-5 sites of OligoMetastatic Non-small cell lung cancer (NSCLC): A Phase III Randomized Controlled Trial
Conditions
- Oligometastatic Disease
- Metastatic Non Small Cell Lung Cancer
Interventions
- RADIATION
-
Local consolidative radiation therapy
Local consolidative radiation therapy (LCRT) to all oligo-metastatic sites in addition to primary disease site
- DRUG
-
Standard maintenance therapy as decided by the treating medical oncologist
Standard maintenance therapy/Observation
Sponsors & Collaborators
-
Tata Memorial Hospital
lead OTHER_GOV
Principal Investigators
-
Dr. Anil Tibdewal · Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-20
- Primary Completion
- 2026-04-20
- Completion
- 2028-04-20
Countries
- India
Study Locations
More Related Trials
-
Low-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy Failure
NCT05547282 ·Status: UNKNOWN ·Phase: NA
-
Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer
NCT05557552 ·Status: RECRUITING ·Phase: NA
-
Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC)
NCT07076693 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients
NCT03489616 ·Status: UNKNOWN ·Phase: NA
-
Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC
NCT02990780 ·Status: UNKNOWN ·Phase: PHASE3
-
Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer
NCT06523673 ·Status: RECRUITING ·Phase: PHASE3
-
Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer
NCT03595644 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy
NCT05552846 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases
NCT07258147 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC
NCT03987087 ·Status: UNKNOWN ·Phase: PHASE2
-
Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer
NCT04212052 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC)
NCT01745445 ·Status: UNKNOWN ·Phase: PHASE2
-
High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer
NCT03598517 ·Status: UNKNOWN ·Phase: NA
-
The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer(NSCLC)
NCT02076477 ·Status: UNKNOWN ·Phase: PHASE3
-
Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy
NCT06187740 ·Status: RECRUITING ·Phase: PHASE1
-
SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma
NCT04351282 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases
NCT05638425 ·Status: RECRUITING
-
Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC
NCT05176067 ·Status: UNKNOWN ·Phase: NA
-
SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors
NCT05387044 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer
NCT02573506 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
NCT05615142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma
NCT05431764 ·Status: RECRUITING ·Phase: PHASE2
-
Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer
NCT06775678 ·Status: RECRUITING ·Phase: PHASE2
-
SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma
NCT05524168 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
NCT05481775 ·Status: WITHDRAWN ·Phase: PHASE2